Bolt Biotherapeutics Inc
(NAS:BOLT)
$
0.7524
0.0202 (2.76%)
Market Cap: 28.69 Mil
Enterprise Value: -43.87 Mil
PE Ratio: 0
PB Ratio: 0.28
GF Score: 40/100 Bolt Biotherapeutics Inc (BOLT) Transcripts
- Q1 2024 Bolt Biotherapeutics Inc Earnings Call TranscriptMay 14, 2024$1.32 (-0.75%)Earnings
- Bolt Biotherapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Bolt Biotherapeutics Inc at Cowen Health Care Conference TranscriptMar 07, 2023
- Bolt Biotherapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 16, 2023
- Bolt Biotherapeutics Inc at Guggenheim Healthcare Talks Oncology Day TranscriptFeb 08, 2023
- Bolt Biotherapeutics Inc at Stifel Healthcare Conference TranscriptNov 16, 2022
- Bolt Biotherapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Bolt Biotherapeutics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 14, 2022
- Bolt Biotherapeutics Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 09, 2022
- Bolt Biotherapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Bolt Biotherapeutics Inc CMC Considerations For In-Human Studies with Drs. Edith Perez And Nathan Ihle TranscriptSep 23, 2020
- 1